166 related articles for article (PubMed ID: 38466704)
1. Incidence and survival of second primary non-Hodgkin lymphoma: A Surveillance, Epidemiology, and End Results-based cohort study.
Yu N; Zhang W; Zhong X; Song X; Li W
PLoS One; 2024; 19(3):e0300330. PubMed ID: 38466704
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and Determinants of Survival for Primary Intestinal Non-Hodgkin Lymphoma: A Population-Based Study.
Singh V; Gor D; Gupta V; Jacob A; Du D; Eltoukhy H; Meghal T
World J Oncol; 2022 Aug; 13(4):159-171. PubMed ID: 36128593
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of Nasopharyngeal Lymphoma in the United States: A Population-Based Analysis of 1119 Cases.
Han AY; Kuan EC; Alonso JE; Badran KW; St John MA
Otolaryngol Head Neck Surg; 2017 May; 156(5):870-876. PubMed ID: 28322119
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
[TBL] [Abstract][Full Text] [Related]
7. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
Xiao M; Lin J; Xiao T; Lin Y; Ye Y
Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
[TBL] [Abstract][Full Text] [Related]
8. Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.
Ayers AA; Lyu L; Dance K; Ward KC; Flowers CR; Koff JL; McCullough LE
Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):699-708.e5. PubMed ID: 31494062
[TBL] [Abstract][Full Text] [Related]
9. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences.
Wu XC; Andrews P; Chen VW; Groves FD
Cancer Epidemiol; 2009 Nov; 33(5):337-46. PubMed ID: 19853554
[TBL] [Abstract][Full Text] [Related]
10. Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?
Chihara D; Oki Y; Fanale MA; Westin JR; Nastoupil LJ; Neelapu S; Fayad L; Fowler NH; Cheah CY
Ann Hematol; 2019 May; 98(5):1169-1176. PubMed ID: 30617643
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and survival outcomes of primary splenic cancers: A SEER population-based study.
Lei Y; Huang Q; Li X; Zheng X; Liu M
Medicine (Baltimore); 2022 Jan; 101(3):e28539. PubMed ID: 35060511
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant.
Pasvolsky O; Bassett RL; Ghanem S; Cuglievan B; Tewari P; Hosing C; Srour S; Ramdial J; Mahadeo KM; Khazal S; Petropoulos D; Popat U; Qazilbash M; Kebriaei P; Champlin R; Shpall EJ; Nieto Y
BMC Cancer; 2023 Dec; 23(1):1258. PubMed ID: 38124057
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and prognostic indicators in laryngeal lymphoma: A population-based analysis.
Hong SA; Tajudeen BA; Choi S; Husain IA
Laryngoscope; 2018 Sep; 128(9):2044-2049. PubMed ID: 29392765
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
15. Primary renal lymphoma: A population-based analysis using the SEER program (1973-2015).
Taneja A; Kumar V; Chandra AB
Eur J Haematol; 2020 May; 104(5):390-399. PubMed ID: 31769538
[TBL] [Abstract][Full Text] [Related]
16. Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database.
Kim JS; Liu Y; Ha KH; Qiu H; Rothwell LA; Kim HC
Cancer Res Treat; 2020 Oct; 52(4):1262-1272. PubMed ID: 32599988
[TBL] [Abstract][Full Text] [Related]
17. [Clinical Characteristics of 219 Patients with Primary Gastrointestinal Non-Hodgkin's Lymphoma].
Li YY; Hu DZ; Wang YF; Zhao ZG; Cao Z; Zhang YZ; Zhang HL; Tian C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):849-854. PubMed ID: 32552946
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Primary B/NKT Non-Hodgkin Lymphomas in Nasopharynx, Nasal Cavity, and Paranasal Sinuses.
Peng J; Qiu J; Cheng D; Rao Y; Mao M; Qiu K; Li J; Chen F; Liu F; Liu J; Mu X; Yu W; Zhang W; Xu W; Zhao Y; Ren J
Otolaryngol Head Neck Surg; 2023 May; 168(5):1107-1118. PubMed ID: 36939485
[TBL] [Abstract][Full Text] [Related]
19. Therapy-related Acute Myeloid Leukemia in Non-Hodgkin Lymphoma Survivors: Risk, Survival Outcomes and Prognostic Factor Analysis.
Joshi U; Bhattarai A; Gaire S; Budhathoki P; Agrawal V; Subedi R; Poudyal BS; Dhakal P; Sham R; Bhatt VR
Hematol Oncol Stem Cell Ther; 2023 Jul; 17(1):79-87. PubMed ID: 37581464
[TBL] [Abstract][Full Text] [Related]
20. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
